At House Hearing, Hemp Industry Begs for More FDA Regulation While Others Seek Less

At House Hearing, Hemp Industry Begs for More FDA Regulation While Others Seek Less

(MedPage Today) -- Wednesday's House hearing on restoring trust in the FDA included something that doesn't happen often: testimony from an industry representative begging for his industry to be regulated. "Lack of uniform quality control standards...

Hemp Industry Expert Tells Congress Businesses Are ‘Begging’ For Federal Regulations At FDA-Focused Committee Hearing

Members of a congressional committee held a hearing on the Food and Drug Administration (FDA) on Wednesday—with a hemp industry expert explaining how the market is “begging” for federal regulations around cannabis products and a staunch prohibitionist congressman invoking musician Elton John’s opposition to marijuana legalization. The House Oversight and Government Reform Committee heard from a wide range of experts at the meeting, titled “Resto…

US Hemp Industry States Its Case To Congress

U.S. Hemp Roundtable General Counsel Jonathan Miller yesterday testified before the House Committee on Oversight and Accountability regarding FDA inaction on CBD and regulating hemp consumables. Hemp Roundtable says the U.S. Food & Drug Administration’s failure to regulate after hemp was legalized in 2018 has resulted in an explosion of potentially dangerous illicit products,  and […] The post US Hemp Industry States Its Case To Congress appeare…

Recap of U.S. Hemp Roundtable General Counsel, Jonathan Miller, Testifying Before House Oversight Committee – U.S. Hemp Roundtable

On Wednesday, April 9th, Jonathan Miller, General Counsel for the U.S. Hemp Roundtable, testified before the House Oversight Committee during a hearing titled “Restoring Trust in FDA: Rooting Out Illicit Products.” Throughout the hearing, Jonathan highlighted the urgent need for federal regulation of hemp-derived cannabinoid products and urged lawmakers to hold the FDA accountable for years of inaction that have created a tumultuous marketplace …

FDA Hammered by Lawmakers on Capitol Hill for Allowing Intoxicating Hemp Industry to Flourish - Business of Cannabis

The US Food and Drug Administration (FDA) was dragged through the mud by lawmakers yesterday, who said its ‘bureaucratic red tape, inefficiencies, and weak oversight’ was responsible for the flood of intoxicating hemp substances across the country. The US House Committee on Oversight and Government Reform held its hearing, dubbed ‘Restoring Trust in the FDA: Rooting Out Illicit Products’, on Wednesday (April 09) to examine the FDA’s apparent fai…

Hemp expert begs Congress to take action

Cannabis and hemp have been in a government purgatory for years, patiently waiting for the feds to decide their fates. The path to federal cannabis rescheduling is paused indefinitely. Meanwhile, a proliferation of legal intoxicating hemp-derived products, thanks to the 2018 Farm Bill, has caused states to take a piecemeal approach to policy (much like cannabis). While these products have exploded in popularity, questions around product safety a…